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ABSTRACT
Objective: Enterococci are important nosocomial agents and due to their potential antimicrobial resistance they have 
a significant role in the dissemination of resistance genes. Currently, these species are described as healthcare concern. 
The aim of this study was to determine vanA and vanB genes in vancomycin resistant enterococci (VRE) strains isolated 
from the various clinical samples in the hospitals in Iran.
Methods: Susceptibility of 235 strains to vancomycin was screened as minimum inhibitory concentration (MIC) by E-
test. The genes encoding modifying vancomycin precursor’s dipeptide termini named as vanA and vanB genes were 
targeted by Taq Man real time PCR assay in vancomycin resistant and vancomycin intermediate resistant Enterococcus 
faecalis and Enterococcus faecium strains.
Results: A total of 235 enterococci were isolated from the clinical specimens. One hundred and ninety three (82.1%) of 
them were defined as E. faecalis, 33 (14.0%) E. faecium, 1/235 (0.4%) E. avium, 1/235 (0.4%) E. raffinosus and 7/235 (3.0%) 
E.  galinarium. The prevalence of vancomycin resistance was 13.6% (32/235) consisting of 18/235 (7.7%) E. faecalis and 
6.0% (14/235) E. faecium. Among the 32 VRE strains, a total of 36 vanA and vanB genes were detected (some isolates 
had both vanA and vanB genes). These resistance genes were not detected in 5 out of 32 (15.6%) isolates.
Conclusion: E. faecalis was more common in clinical samples and vanA (58.3%) gene was the predominant gene among 
the VRE isolates. The current study showed that Taq Man real time PCR assay is the useful, precise and rapid detection 
of vancomycin resistance genes. J Microbiol Infect Dis 2013;3(4): 192-198
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Vankomisin dirençli enterokok’larda (VRE) vanA ve vanB gen prevalansının Taq Man real 
time PCR assay ile araştırılması
ÖZET
Amaç: Enterokoklar önemli hastane enfeksiyonu etkenidirler ve antimikrobiyal direnç potansiyelleri nedeniyle rezistans 
genlerinin yayılmasında önemli rolleri bulunmaktadır. Günümüzde bu mikroorganizmalar önemli bir halk sağlığı sorunu 
olarak tanımlanmıştır. Bu çalışmada İran’daki bazı hastanelerde değişik klinik örneklerden izole edilen vankomisin di-
rençli enterokok (VRE)’lar arasında vanA ve vanB genlerinin sıklığının araştırılması amaçlandı. 
Yöntemler: Suşların vankomisin duyarlılıkları E test yöntemiyle araştırılarak minimum inhibitör konsantrasyon (MİK) 
değerleri belirlendi. Vankomisin dirençli ve vankomisine orta düzeyde dirençli Enterococcus faecalis ve Enterococcus 
faecium suşlarında Taq Man real time PCR assay ile vankomisin direncini kodlayan vanA ve vanB genleri hedeflendi. 
Bulgular: Çalışma süresince klinik örneklerden toplam 235 enterokok suşu izole edildi. Bu şuşlardan 193’ü (% 82,1) E. 
faecalis, 33’ü (% 14,0) E. faecium, 1’i (% 0,4) Enterococcus avium, 1’i (% 0,4) Enterococcus raffinosus ve 7’si (% 3,0) Ente-
rococcus galinarium olarak tanımlandı. Toplam 235 enterokok suşunda 32’si (% 13,6) VRE idi. Toplam 235 suştan 18 (% 
7,7)’i E. faecalis ve 14’ü (% 6,0) E. faecium idi. Bu suşların 27 (% 84,4)’sinde vanA ve vanB genleri belirlendi (bazı izolatlar 
hem vanA ve hem vanB genlerine sahip idi). Suşların 5’inde (% 15,6) direnç geni belirlenemedi.
Sonuçlar: Araştırmamızda klinik VRE suşları arasında E. faecalis suşlarının sıklıkta olduğu ve vanA geninin vankomisin 
direncine sebep olan en sık gen olduğu gözlendi. Bu çalışma Taq Man real time PCR assay testinin vankomisin direnç 
genlerinin gösterilmesinde kullanılabilen, kesin ve hızlı bir test olduğunu göstermektedir. 
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INTRODUCTION
Enterococci are Gram-positive and non-motile bac-
teria. They have some biochemical characteristics; 
oxidase and catalase negativity, 6.5% NaCl toler-
ance, and hydrolysis of bile in bile esculin agar.1 
Due to various different of antibiotic resistance 
genes, they are intrinsically resistant against amino-
glycosides, macrolides, β-lactams and semisynthet-
ic penicillins.2 It has been shown in many studies 
that there was a trend in increasing of glycopeptides 
resistance in enterococci and vancomycin resistant 
enterococci (VREs) have gained much attention in 
the last decade.3 Researchers have described mo-
bile genetic elements (transposons and plasmids) 
as resistance genes transferring between entero-
cocci.4-6 One of the common resistance mecha-
nisms to glycopeptides is vancomycin, dipeptide like 
termini (D-Ala- D-Lac) encoded by vanA and vanB 
clusters which, prompt to low affinity for glycopep-
tides.3 More than 30 different species of enterococci 
have been identified but in Enterococcus faecalis 
and Enterococcus faecium are mostly isolated bac-
teria among them.5,7
After the first detection of vancomycin resistant 
enterococci (VREs) in 1980, they have emerged 
as important nosocomial pathogens in worldwide 
(4 and 8). Studies have shown that VRE were dis-
seminated through the world. Currently, VREs is de-
scribed as main concern in healthcare.4,9 Findings 
concerning the prevalence of vancomycin resistant 
genes are necessary for controlling and proper 
treatment of enterococcal infections.2 Many studies 
have mentioned that the resistance to vancomycin 
is complex process and needs to presence of mul-
tiple genes. Seven gene clusters were investigated 
in VRE including vanA, vanB, vanC1, vanC2, vanD, 
vanE, and vanG. Genes (vanA and vanB) encod-
ing dipeptide like termini are responsible for high or 
moderate level vancomycin resistance.3,7,9 The iso-
lates having vanA are usually high resistant to van-
comycin and teicoplanin due to vanA gene cluster. 
This resistance is mediated by vanA gene cluster by 
D-Ala-D-Lac encoded dipeptide like termini. VanB 
gene cluster produce D-Ala - D-Lac dipeptide like 
termini, and this protein provide moderate to severe 
vancomycin resistance but not to teicoplanin.7
Many studies have been conducted in differ-
ent countries for the detection of vanGenotypes, 
prevalence and risk factors for VRE infections. For 
this reason, this study mainly was designed for the 
determination of VRE in clinical samples based 
on vanA and vanB genes. Rapid detection of VRE 
strains having vanA and vanB genes by Taq Man 
real time PCR assay is the main aim of this study. 
METHODS
A total of 235 enterococci were collected from dif-
ferent clinical samples of patients with suspected 
of clinical infection including urine, blood, sputum, 
CSF, pleura, fluid, and wound from June to Novem-
ber 2011 in 6 hospitals in Qazvin and Tehran, Iran. 
All of the enterococcal isolates were identified based 
on the following microbial tests consisting of growth 
in Azid Maltose Agar Medium, Gram stain, oxidase 
and catalase reaction, growth on bile esculin agar 
and 6.5% NaCl media as described elsewhere.10 
Differentiation test for enterococci was done by the 
scheme utilized in previously published for identity 
of enterococci including fermentation of carbohy-
drates (sorbitol, arabinose, raffinose, mannitole and 
sucrose), motility and pigmentation.10,11
Susceptibility of microorganisms
Susceptibility test for 235 enterococci was per-
formed by E-test according to the Clinical Labora-
tory Standard Institute (CLSI) guideline.12 Suspen-
sions (1.5 x 108 cfu/ml) were prepared from the 
isolates and adjusted with 0.5 McFarland standard 
(measured by spectrophotometric analysis Gen-
syse 10 UV spectrum, USA) as for described in 
the CLSI guideline.12 All isolates tested by vanco-
mycin E-test strips (AB BIODISK, Solna, Sweden) 
on the Mueller-Hinton agar medium (Merck, Ger-
many). Briefly 0.2 ml of bacterial suspension in nor-
mal saline was spreaded onto Muller-Hinton agar 
medium and the E-test strips were applied to the 
inoculated culture plates separately by using a tem-
plate, as recommended by the manufacturer, and 
the plates were incubated at 35°C for 24 hours. The 
MICs breakpoints for vancomycin were determined 
by manufacturer’s recommendation and the MICs 
were interpreted at the point of intersection between 
the inhibition zone and the E-test strip. A standart E. 
faecalis ATTC 29212 strain was used as a control.
DNA Extraction
After performed E-test the isolates with 4<MIC<32 
and MIC≥32 breakpoints were screened. Two pure 
colonies were emulsified in 10 ml of sterile Loria 
Bertani broth (Liofilchen, Italy) and incubated over 
night in shaken incubator (35°C for 24 hours) in 
ambient air to reach the turbidity equivalent to 0.5 
McFarland standards. Cells harvested by centri-
fuge 8000 rpm for 5 minutes. The pellets consist-
ing of bacterial cells were used for DNA extraction 
process. Following boil and freezing procedure (1 
min 96°C and -20°C for 20 min, in this study) total 
DNA extraction was carried out by high pure DNA 
extraction kits (Roche, Mannheim, Germany). Dried Mirzaei B, et al. Detection of vanA and vanB genes in VRE 194
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DNA was dissolved in 50 µl of distilled water. Con-
sequently, quantity of DNA was measured by Nano-
drope (Spectrophotometer 1000) and adjusted to 
500 ng/µL. 
DNA confirmation test
Dried DNA was measured by PCR by utilizing rrs 
gene (16srRNA). Primer previously was utilized. 
Sequences of forward and reverse primer for 320 
bp PCR product were 5/-GGATTAGATACCCTG-
GTGGTAGTCC-3/ and 5/-TCGTTGCGCACCT-
TAACCAAC-3/  (4).  The  Amplification  procedure 
was made by 20 µl as final volume containing 10 
µl master amplicon, Primer Forward 2.5 µl, Primer 
Reverse 2.5 µl, and Template 5 µl. PCR process 
was optimized with E. faecalis V583 & E. faecium 
BM4147 as positive genotypes. Standardization of 
PCR performed by following condition: Denaturation 
95°C for 30 sec (1 cycle), annealing 54°C for 1 min 
in 30 cycles. PCR products (320 bp) were electro-
phoresed and stained by gel red in 2% agarose gel 
(Max Pure Sgarose, Spain). Band of the amplicon 
was observed by Gel logic 212pro. 
Figure 1. Amplification  plots 
for standardization of vanA 
gene positive control BM4147 
(A), and for vanA positive in a 
clinical sample (B)
Taq Man Real time PCR assays
For rapid detection of high and moderate vancomy-
cin resistant enterococci (vanA and vanB genes in 
this study), vancomycin resistance determinants of 
vanA and vanB were targeted by real Time PCR. 
Detection of these genes was performed by an in-
strument (ABI7500, USA).
Designation of primers and probes
Reference vanA and vanB sequences representing 
each of vanA and vanB (vanB1/vanB2/vanB3) were 
assembled from the GenBank data base (http://
www.ncbi.nlm.gov/GenBank). Reference sequenc-
es with Accession number (M97297) and accession 
number (U00456.1) were used for vanA and vanB 
genes respectively. These sequences were aligned 
by using computer software and primer and probes 
were designed by beacon designer version 7 soft-
ware. Two primers and taq man probes were de-
signed specifically to detect genes encoding D-Ala-
D-Lac dipeptide like termini. Probe reporters dyes 
(at 5/ position were either JOE or HEX) and quench-
er were (BHQ1 and Tamra). Sequences of primers 
and probes were described as vanA forward and 
reveres primer including 5/-ATCAACCATGTTGAT-
GTAGC-3/ and 5/-AAGGGATACCGGACAATTCA-3/ 
for 136 bp amplicon. Sequence of vanA probe was Mirzaei B, et al. Detection of vanA and vanB genes in VRE 195
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5/-TCCATCTTCACCTGACTTGCCA-3/. Sequence 
of designed forward reverse primer and probe 
for  vanB gene including 5/-ACCCTGTCTTTGT-
GAAG-3/, 5/-GAAATCGCTTGCTCAAT-3/ for am-
plification of 121bp product and 5/-TCCATCATATT-
GTCCTGCTGCTTCTAT-3/. Taq Man real Time PCR 
optimized by reference strains as positive controls 
(isolates producing vanA BM4147 and vanB V583 
as positive controls were obtained from microbial 
collection of the Pasteur Institute of Iran. Amplifica-
tion was performed by final volume 23 µl consisting 
(10 µl ABI master mix, 2.5 pmol of each primer, 1.5 
pmol of each probe and 5 µl template. Real time 
PCR cycle conditions were denaturation at 95°C for 
15 sec, annealing at 52°C for 15 sec and extension 
at 72°C for 1 min (35 cycles). Amplification plot of 
positive controls and clinical isolates are showed in 
Figure 1 and 2.
Figure 2.  Amplification  plots 
for standardization of vanB 
gene positive control BM4147 
(A), and for vanB positive in a 
clinical sample (B)
RESULTS
We  identified  193  strains  (82.1%)  as  Enterococ-
cus faecalis, 33 strains (14.0%) as E. faecium, 
1 strain (0.4%) as E. avium, 1 strain (0.4%) as E. 
raffinosus and 7 strains (3.0%) as E. galinarium 
respectively. The isolates were obtained from CSF 
(5 strains), blood (21 strains), urine (165 strains), 
and other clinical samples (44 strains) respectively. 
Determined minimum inhibitory concentration (MIC) 
breakpoints in this study are listed in Table 1. Based 
on the E-test results, 32 (13.6%) out of 235 isolates 
were accepted as VRE. Fourteen (43.8%) of them 
were E. faecalis and 18 (56.2%) of them were E. 
faecium. Additionally, 28 (11.9%) enterococci were 
interpreted as intermediate resistant to vancomycin 
(Table 1).
Table 1. Results of vancomycin susceptibility test to the 
species level for the clinical isolates of enterococci by E- 
test (n=235)
Vancomycin MIC
(mcg/ml)
Susceptible (≤4) Intermediate
(8-16) Resistant (≥32)
E. faecalis (n=193) 153 (79.3) 22 (11.4) 18 (9.3)
E. faecium (n=33) 18 (54.6) 1 (3) 14 (42.4)
E. galinarium (n=7) 2 (28.6) 5 (71.4)
E. raffinosus (n=1) 1 (100)
E. avium (n=1) 1 (100)
*Data presented as n (%).Mirzaei B, et al. Detection of vanA and vanB genes in VRE 196
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Among the 32 VRE isolates, vanA and vanB 
genes were observed in 27 (84.4%). The only vanA 
gene was detected in 5 (27.8%), vanB gene was 
detected in 5 (27.8%) of 18 E. faecalis and the only 
vanA gene was detected in 7 (50%), vanB gene 
was detected in 1 (7.1%) of 14 E. faecium by Taq 
Man real time PCR (Table 2). Both vanA and vanB 
genes was detected in 6 (33.3%) of 18 E. faecalis 
and 3 (21.4%) of 14 E. faecium strains. We detected 
neither vanA, nor vanB gene in 2 of E. faecalis and 
3 of E. faecium strains. The Taq man real time PCR 
assay disclosed as vanA is the predominant gene 
among the VRE strains (21 vs. 15). The vanA or 
vanB genes were not detected among the interme-
diate vancomycin resistant enterococci during the 
study (Table 2). The distribution of MIC breakpoint 
values determined by E-test for both species of E. 
faecalis and E. faecium to vanA and vanB genes 
are summarized in Table 3.
Table 2. Distribution of vanA and vanB genes to vanco-
mycin susceptibility test results of enterococci (n=226)
Vancomycin MIC
(mcg/ml)
Susceptible
(≤4)
Intermediate
(8-16)
Resistant
(≥32)
Enterococcus
faecalis (n=193)  153 (79.3) 22 (11.4) 18 (9.3)
vanA 0 0 5 (27.8)
vanB 0 0 5 (27.8)
vanA and vanB 0 0 6 (33.3)
Enterococcus
faecium (n=33) 18 (54.6) 1 (3) 14 (42.4)
vanA 0 0 7 (50)
vanB  0 0 1 (7.1)
vanA and vanB 0 0 3 (21.4)
Data presented as n (%), MIC, Minimum inhibitory con-
centration.
Table 3. Distribution of minimum inhibitory concentration 
(MIC) breakpoint values to vanA and vanB genes by the 
E-test.
Microorganism MIC (µg/
ml)
No. Total, n (%)
Enterococcus
faecalis (n=16)
vanA
>256
256
128
1
1
3
5 (27.8)
vanB 64
32
2
3 5 (27.8)
vanA and vanB
256
196
64
1
1
4
6 (33.3)
Enterococcus
faecium (n=11)
vanA
>256
256
196
1
4
2
7 (50)
vanB 96 1 1 (7.1)
vanA and vanB 256
196
2
1 3 (21.4)
DISCUSSION
Enterococci  as  1%  of  intestinal  microflora  in  hu-
mans have been observed as more common noso-
comial infection in worldwide. Among them E. fae-
calis and E. faecium are the most common isolated 
microorganisms from the human stool. In current 
study, our results for the frequency of enterococci 
in clinical samples in hospitals have similarity to 
other studies in this subject.8,13,14 After  identifica-
tion of first VRE strain in early 1980, colonization 
and infectious diseases caused by these bacteria 
have been enhanced. Currently, these bacteria are 
important cause of nosocomial infections (NIs) and 
due to multidrug resistance features and treatment 
failures, the mortality rate in hospitalized patients 
are increased.15,16 The results of the entire study 
show that the dissemination of VRE in hospitals in 
Qazvin and Tehran, Iran. The phenotypic methods 
such as E-test are the convenient and useful meth-
ods for determining of MIC values for vancomycin in 
enterococci. Our result are in accordance with the 
other studies which conducted by Sharifi et al. in 
Iran, but, in contrast to the results of the study which 
performed by Pérez-Hernández et al.13,17
Horizontal gene transfer has an important role 
for the dissemination of resistance genes in en-
terococci and transposon (Tn1546) also has an 
important role for the dissemination of vancomycin 
resistance genes. Although primarily vanA cluster 
(Tn1546 and Tn5482) was identified in E. faecium, 
it has also been detected in E. faecalis. The vanB 
gene cluster exists in Tn1546 and it has been identi-
fied in E. faecalis and E. faecium strains.18 The real 
time PCR assay is rapid approach for the detection 
of vancomycin resistance genes, more specific than 
traditional phenotypic methods for identification of 
high level and intermediated vancomycin resis-
tance. Several real time PCR protocols have been 
developed for the detection of resistance genes in Mirzaei B, et al. Detection of vanA and vanB genes in VRE 197
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microorganisms.7 The primer and probes used this 
study were designed by the Beacon Designer 7 
software and concentration of primer and probes, 
annealing,  temperature,  amplification  cycle  with 
pure  and  defined  concentration  of  template  DNA 
were carefully adjusted in order to optimize to Taq 
Man real time PCR assay. Our optimized Taq Man 
real time PCR assay had 96% similarity of pheno-
typic methods including E-test for the description of 
VRE. Precise and rapid detection of vancomycin re-
sistance genes enhances of the isolation accuracy 
of VRE from various clinical samples. Therefore 
molecular approaches such as Taq Man real time 
PCR assay are useful methods and then they can 
help to the clinicians for decision of appropriate an-
tibiotics to the patients suffering from the infections 
caused by resistant microorganisms including VRE.
In current study 32 (13.6%) of the 235 clinical 
isolates were defined as vancomycin resistant by 
E-test. In addition, 27 (84.4%) out of 32 VRE strains 
had vanA or vanB or both and among them, 5 VRE 
isolates were negative for both vanA or vanB genes 
by Taq Man real time PCR assay (Table 1 and Table 
2). The possible mechanism for emerging of vanco-
mycin resistance among enterococci in the region 
probably occurred by high mutation frequency in li-
gase enzyme joining the two dipeptide termini such 
as D-Alanyl-D-Alanin.19 Among the 32 VRE isolates, 
both vanA and vanB gene were determined in 3 
strains of E. faecium and in 6 strains of E. faeca-
lis respectively. The reason of this phenomena is 
unknown but instability in enterococci genome and 
transduction process or up and down regulation of 
genes probably can be considerable.19 In this study, 
five VRE isolates had a MIC value of ≥32 mcg/ml by 
E-test but, neither vanA nor vanB genes were de-
tected by real time PCR technique suggesting the 
presence of other vanGenes or other mechanisms 
responsible for the vancomycin resistance.23
In conclusion, due to the higher existence of 
vancomycin resistance related genes in VRE is ne-
cessitated to prevent of their dissemination in the 
hospital. We think the microbiology laboratories in 
the hospitals must be well equipped with the new 
and modern techniques for rapid detection of van-
comycin resistance. The current study showed that 
Taq Man real time PCR assay is the useful, precise 
and rapid detection of vancomycin resistance genes 
in the clinical microbiology laboratory.
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